News

Echosens and Novo Nordisk Announce Partnership to Combat NASH

June 27, 2022

The partnership between Echosens and Novo Nordisk is intended to increase awareness and early diagnosis of non-alcoholic steatohepatitis (NASH).

MHRA Updates Guidance on Handling of Approved or Pending DCP and MRP

June 27, 2022

The new guidance outlines the approach the MHRA intends to take for products approved or pending in a decentralized procedure or mutual recognition procedures.

Novartis to Invest $250 Million for R&D of Neglected Tropical Diseases

June 24, 2022

Novartis will endorse the Kigali Declaration on neglected tropical diseases and invest $250 million for R&D.

GSK Announces £1 Billion R&D Investment in Fighting Infectious Diseases in Lower-Income Countries

June 24, 2022

GSK will invest £1 billion in furthering R&D in malaria, tuberculosis, and HIV, as well as neglected tropical diseases.

Kindeva Drug Delivery Completes Acquisition of iPharma Labs

June 22, 2022

Kindeva’s acquisition of iPharma will increase the company’s inhalation formulation outsourcing capabilities.

Aizon Launches GxP Compliant Data Processing Solution

June 22, 2022

Aizon Digitize is designed to help life science manufacturers transition data from paper to digital.

FDA Leaders Seek to Build Public Trust in Science and Gain Support for Regulation

June 22, 2022

FDA is at a pivotal moment because of important gains in medical treatment based on science.

Sustainable Medicines Packaging Award Winners to be Announced at Connect in Pharma

June 21, 2022

Connect in Pharma will host an awards ceremony to showcase innovations in sustainable pharmaceutical packaging.

EMA Starts Rolling Review of Adapted COVID-19 Vaccines

June 21, 2022

The agency will review laboratory study and CMC data on the bivalent vaccine that targets two strains of the SARS-CoV-2 virus.

International Collaboration on Pharmaceutical Regulations

June 21, 2022

Lessons learned from the COVID-19 pandemic about the benefits of international collaboration were discussed in a May 2022 workshop.